Glia maturation factor (GMF), a primarily CNS localized protein was discovered and characterized in our laboratory. We previously demonstrated that GMF is the upstream regulator for excessive production and release of proinflammatory cytokines/chemokines in brain cells leading to the destruction of oligodendrocytes, the myelin forming cells, and neurons. We also reported that mice lacking endogenous GMF (GMF-deficient, GMF-KO) were resistant to myelin oligodendrocyte glycoprotein peptide ) induced EAE, since immunization induced only delayed EAE with diminished severity. In the present study we show that a replication-defective adenovirus-GMF construct caused expression of GMF in CNS of GMF-KO mice and reinstated MOG 35-55 induced early and severe EAE. Our results show that MOG 35-55 immunization caused only a muted EAE and inflammation/ demyelination in mice lacking endogenous GMF. The diminished incidence of EAE in GMF-KO mice was consistent with the significantly reduced expressions of cytokines/chemokines. The muted severity of EAE in GMF-KO mice was restored to full blown levels upon reintroduction of GMF using an adeno-GMF-virus (Adv-GMF) vector. Consistent with the clinical findings, histological examination of the CNS of mice with EAE revealed profound differences between wild type (Wt), GMF-KO, and GMF-KO mice with re-introduced GMF (GMF-KO+Adv-GMF). Spinal cord sections from mice with EAE were analyzed for the infiltration of mononuclear cells (inflammation) and myelin loss (demyelination). In Wt mice, 40% of spinal cord quadrants were positive for demyelination and 45% of spinal cord quadrants were positive for inflammation at the peak of EAE. Drastically reduced infiltrates (15%) and demyelination (10%) were found in GMF-KO mice that developed reduced severity of EAE. Upon GMF reintroduction in GMF-KO mice, MOG 35-55 immunization caused extensive monocytes infiltration (48%) and demyelination (46%), similar to that observed in the immunized Wt mice. The levels of cytokine/chemokine in the spinal cords of mice at three time points, corresponding to the onset, peak severity and recovery period of EAE, show a distinct pattern of very large increases in IFN-γ, TNF-α, GM-CSF and MCP-1 in Wt and GMF-KO+Adv-GMF mice compared to GMF-KO and GMF-KO+Adv-LacZ mice.
Introduction
Multiple sclerosis (MS) is a disabling inflammatory demyelinating autoimmune disease of the central nervous system (CNS) that affects an estimated 350,000 Americans and over a million individuals worldwide. It is one of the main causes of neurological disabilities among young adults. Pathologically, MS is characterized by the loss of the myelin sheath around neurons, gliosis and death of neurons (Al-Omaishi et al., 1999) . Much of our current knowledge about contributing factors of MS is based on animal models of experimental autoimmune encephalomyelitis (EAE), such as: C57Bl/6/ MOG , SJL/PLP139-151 and adoptive transfer-EAE (AT-EAE). Several theories for the pathogenesis of MS exist and implicate transendothelial infiltration of reactive T cells, proinflammatory cytokines/chemokines, as well as activated microglia and astrocytes in CNS. Additionally, the natural process of remyelination is also disturbed (Jurewicz et al., 2007; Karnezis et al., 2004) . Since the pathogenesis of MS is not clear, an effective and definitive treatment is not available so far.
Glia maturation factor (GMF), a primarily CNS localized protein, was isolated, sequenced and cloned in our laboratory (Kaplan et al., 1991; Lim et al., 1989 Lim et al., , 1990 Zaheer et al., 1993 Zaheer et al., , 1995a . We reported earlier that GMF is a major immunomodulator and required for induced expression of GM-CSF in astrocytes. The GMF-dependent expression of GM-CSF then induces expression of a number of proinflammatory cytokines/chemokines in microglia that leads to the death of oligodendrocytes, the myelin producing cells (Zaheer et al., 2007b) . We also reported that, compared to wild type mice, GMF-deficient mice (GMF-KO) were resistant to actively
